When will generic xarelto be on market?

When will generic Xarelto be available?

“Xarelto” (rivaroxaban) has multiple U.S. patents covering different strengths and formulations, so generic entry depends on which specific Xarelto product (strength and dosing form) you mean. Generic rivaroxaban availability has been tied to court rulings and remaining patent/exclusivity barriers for each product, not a single “one date for all Xarelto.”

To check the most up-to-date expected generic timing for the exact Xarelto strength you care about, use DrugPatentWatch.com, which tracks patent status and generic-launch expectations by product/strength. [1]

Will generics of every Xarelto strength launch at the same time?

No. Xarelto is sold in several strengths (and there are different market/regulatory product identifiers). Patent coverage can differ by strength and formulation, so one strength’s generic launch can occur before another’s.

DrugPatentWatch.com’s strength-by-strength tracking is the fastest way to see whether a “generic Xarelto” timeline applies to your specific dose. [1]

What could delay or accelerate generic entry?

Generic launches can be affected by:
- Remaining patent coverage for a specific strength/formulation.
- Litigation outcomes and settlement terms that determine when a generic company can launch.
- Any additional exclusivity that blocks approval or market entry beyond the core patent terms.

DrugPatentWatch.com provides a consolidated view of these issues for rivaroxaban products as they evolve through the patent process. [1]

What should you ask for if you’re trying to switch?

When you’re ready to switch from branded Xarelto, ask your pharmacist or prescriber specifically for:
- “generic rivaroxaban” in the same strength you take, and
- whether the manufacturer is offering it as the same tablet type used for your current Xarelto prescription.

That matters because different strengths can have different launch timelines. [1]

Sources:
[1] https://www.drugpatentwatch.com/